Stock Events

Stock Events

Pharming Group N.V. 

€13.9
0
-€0.2-1.42% Friday 19:46

Statistics

Day High
-
Day Low
-
52W High
17.2
52W Low
6.75
Volume
-
Avg. Volume
13
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q4 2025
Next
0
0
0
0.01
Expected EPS
0.00008558
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PHG.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Carlisle Companies
CSL
Mkt Cap14.28B
CSL Behring competes in the plasma-derived and recombinant therapeutic products space, similar to Pharming's focus on protein replacement therapies.
Takeda Pharmaceutical
TAK
Mkt Cap57.12B
Takeda Pharmaceutical Company has a strong presence in the rare diseases market, directly competing with Pharming's portfolio.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.49B
BioMarin Pharmaceutical focuses on enzyme replacement therapies for rare genetic disorders, competing with Pharming's approach to treatment.
Vertex Pharmaceuticals
VRTX
Mkt Cap110.97B
Vertex Pharmaceuticals engages in the treatment of cystic fibrosis and other rare diseases, presenting competition in the rare disease market.
AMGEN
AMGN
Mkt Cap189.22B
Amgen operates in the biotechnology field focusing on rare diseases among other areas, making it a competitor in the biopharmaceutical market.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.17B
Regeneron Pharmaceuticals is involved in developing and marketing products for rare diseases, among other areas, competing with Pharming.
GSK
GSK
Mkt Cap116.3B
GlaxoSmithKline has a diverse portfolio including treatments for rare diseases, competing with Pharming in various therapeutic areas.
Pfizer
PFE
Mkt Cap153.13B
Pfizer has a broad portfolio that includes treatments for rare diseases, making it a competitor in the pharmaceutical and biotech industry.
Sanofi
SNY
Mkt Cap113.88B
Sanofi focuses on rare diseases, multiple sclerosis, and oncology, among others, competing with Pharming in the rare disease space.

About

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K" inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Show more...
CEO
ISIN
US71716E1055

Listings

F
DE
PHG.F
STU
DE
PHG.STU
MU
DE
PHGN.MU
XETRA
DE
PHGN.XETRA

0 Comments

Share your thoughts

FAQ

What is Pharming Group N.V. stock price today?▼
The current price of PHG.STU is €13.9 EUR — it has decreased by -1.42% in the past 24 hours. Watch Pharming Group N.V. stock price performance more closely on the chart.
What is Pharming Group N.V. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pharming Group N.V. stocks are traded under the ticker PHG.STU.
Is Pharming Group N.V. stock price growing?▼
PHG.STU stock has risen by +0.72% compared to the previous week, the month change is a +14.88% rise, over the last year Pharming Group N.V. has showed a +100% increase.
When is the next Pharming Group N.V. earnings date?▼
Pharming Group N.V. is going to release the next earnings report on May 07, 2026.
What were Pharming Group N.V. earnings last quarter?▼
PHG.STU earnings for the last quarter are 0.01 EUR per share, whereas the estimation was 0 EUR resulting in a +366.67% surprise. The estimated earnings for the next quarter are N/A EUR per share.
In which sector is Pharming Group N.V. located?▼
Pharming Group N.V. operates in the Other sector.
When did Pharming Group N.V. complete a stock split?▼
Pharming Group N.V. has not had any recent stock splits.